Corticotropin-releasing factor (human) (acetate)

Référence NB-64-24813-1mg

Conditionnement : 1mg

Marque : Neo Biotech


Remove All

Corticotropin-releasing factor (human) (acetate)

Copy Product Info

Synonyms:

Catalog No. T37111 Copy Product Info
Human CRF acetate is a chemical compound that effectively stimulates the synthesis and secretion of adrenocorticotropin in the anterior pituitary.
For research use only—not for human use. No sales to individuals. Use as intended only.

Product Information

Bioactivity
Description
Human CRF acetate is a chemical compound that effectively stimulates the synthesis and secretion of adrenocorticotropin in the anterior pituitary.
In vitro
CRF enhances the excitability of type II dlBNST neurons via the activation of the AC-cAMP-PKA pathway, leading to pain-induced aversive responses[1].
In vivo
In rats that received an injection of CRF (1 nmol/side), the duration spent in the drug-paired compartment during the test session (314±22 s) was significantly reduced compared to the time spent in the same compartment during the preconditioning session (520±18 s)[1].
Chemical Properties
Relative Density.no data available
SequenceH-{DL-Ser}-{DL-Glu}-{DL-Glu}-{DL-Pro}-{DL-Pro}-{DL-xiIle}-{DL-Ser}-{DL-Leu}-{DL-Asp}-{DL-Leu}-{DL-xiThr}-{DL-Phe}-{DL-His}-{DL-Leu}-{DL-Leu}-{DL-Arg}-{DL-Glu}-{DL-Val}-{DL-Leu}-{DL-Glu}-{DL-Met}-{DL-Ala}-{DL-Arg}-{DL-Ala}-{DL-Glu}-{DL-Gln}-{DL-Leu}-{DL-Ala}-{DL-Gln}-{DL-Gln}-{DL-Ala}-{DL-His}-{DL-Ser}-{DL-Asn}-{DL-Arg}-{DL-Lys}-{DL-Leu}-{DL-Met}-{DL-Glu}-{DL-xiIle}-{DL-xiIle}-NH₂
Sequence ShortSEEPPXSLDLXFHLLREVLEMARAEQLAQQAHSNRKLMEXX
Storage & Solubility Information
StorageStore under nitrogen,Keep away from direct sunlight, Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 µL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 µL Tween 80 and mix well until fully clarified.

3) Add 450 µL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

Keywords

Corticotropinreleasing factor (human) (acetate)Corticotropin-releasing factorCorticotropin releasing factor (human) (acetate)
Related Tags: Corticotropin-releasing factor (human) (acetate) in vivo | Corticotropin-releasing factor (human) (acetate) in vitro